Moderna COVID vaccine trial participant Dan O’Connell

John Williams

FILE – In this March 16, 2020, file photo, Neal Browning receives a shot in the first-stage safety study of a potential vaccine for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle. Moderna Inc., said Monday, Nov. 16, its COVID-19 vaccine is proving to be highly effective in a major trial. (AP Photo/Ted S. Warren, File)

Media relations consultant Dan O’Connell joins John Williams to describe his experience participating in the Moderna COVID vaccine trial. It was found today to have 94% efficacy.

COVID-19 risk as determined by nonprofit Covid Act Now.

Coronavirus Resources from the CDC

Coronavirus by State

COVID-19 Testing Vs. Confirmed Cases by State

Interactive: Coronavirus Timeline

The Mincing Rascals

More The Mincing Rascals

The John Williams Show
Weekdays 9 a.m. - noon JohnWilliams

Focusing on current events, John discusses the news of the day, sports, television programs, movies, and books with a thoughtful perspective and quirky sense of humor. Inquisitive and curious by nature, he asks what listeners want to know and his guests never get a pass on the tough questions. (Click for more.)

Popular